And i've clearly elucidated why their current production costs...

And i've clearly elucidated why their current production costs are almost certainly going to be below current spodumene pricing, how do projected outgoings of $20,000,000 AUD for the quarter and shipped (sold) product of 38,000 tonnes at, at least $790 AUD ($550 USD floor price) possibly equate to higher costs than income? With production volumes likely to be much higher than shipped volumes in any case.

Is a low P/E ratio a fair metric for an early stage producer which is still growing?

Just because someone came to 'your' forum and upset you doesn't make it reasonable to come here and spray ill considered nonsense, just use the ToS to get the mods to adjudicate and deal with individual concerns rather than this nonsense comparison of manhoods.